Acelrx pharmaceuticals reports fourth quarter and full year 2021 financial results

Hayward, calif., march 10, 2022 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx), (acelrx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today reported its fourth quarter and full year 2021 financial results.
ACRX Ratings Summary
ACRX Quant Ranking